SCHEDULE 13G/A: BlackRock Discloses 9.4% Passive Stake in Microchip Technology

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.4% beneficial ownership stake in Microchip Technology Incorporated as of March 31, 2025.

Summary

• BlackRock, Inc. filed Amendment No. 12 to Schedule 13G concerning its beneficial ownership of common stock in MICROCHIP TECHNOLOGY INCORPORATED.
• As of March 31, 2025, BlackRock, Inc. beneficially owns an aggregate of 50,719,406 shares of Microchip Technology Incorporated common stock.
• This ownership represents 9.4% of the total outstanding common stock of Microchip Technology Incorporated.
• BlackRock, Inc. holds sole voting power over 47,353,121 shares and sole dispositive power over all 50,719,406 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
• BlackRock Fund Advisors, a subsidiary of BlackRock, Inc., is identified as an entity that beneficially owns 5% or greater of the outstanding shares of the security class.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing (Schedule 13G) disclosing beneficial ownership. It is factual and does not contain information that would inherently indicate a positive or negative sentiment for the issuer, Microchip Technology Incorporated, beyond the confirmation of a significant institutional investment by BlackRock.

Positives

• BlackRock, a prominent institutional investor, holding a significant 9.4% stake in Microchip Technology can be interpreted as a vote of confidence in the company's long-term prospects and stability.

Future Outlook

NA

Management Comments

• BlackRock, Inc. certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

This filing is a routine disclosure by a major institutional asset manager, BlackRock, Inc., regarding its passive investment stake in a publicly traded company, Microchip Technology Incorporated. Such filings are common in the financial industry as large funds manage diversified portfolios, often including significant positions in established technology companies like Microchip.

Comparison to Industry Standards

• This Schedule 13G filing is a standard regulatory disclosure for institutional investors holding more than 5% of a company's stock, aligning with SEC requirements for transparency in beneficial ownership.
• BlackRock's 9.4% stake is a significant passive investment, typical for large asset managers like Vanguard, State Street, or Fidelity, which often hold substantial positions across numerous public companies as part of their index or actively managed funds.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, potentially signaling institutional confidence in Microchip Technology.
• Management: Awareness of a large, passive institutional investor holding a substantial portion of the company's stock.

Next Steps

• BlackRock, Inc. will continue to file amendments to Schedule 13G as required by SEC regulations if there are material changes to its beneficial ownership of Microchip Technology Incorporated.

Key Dates

Keywords

Microchip Technology, BlackRock, Schedule 13G, beneficial ownership, common stock, institutional investment, semiconductor industry